Compare Stocks: ILMN, QGEN, TMO, and DHR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DHR Danaher	$220.15 +1.2%	$211.38	$160.93 ▼ $242.80	$154.52B	0.76	4.61 million shs	3.93 million shs
ILMN Illumina	$278.17 +5.1%	$227.18	$88.00 ▼ $309.35	$42.00B	1.41	4.55 million shs	1.89 million shs
QGEN Qiagen	$45.42 +2.0%	$43.47	$32.53 ▼ $57.81	$9.35B	0.61	2.31 million shs	1.26 million shs
TMO Thermo Fisher Scientific	$658.23 +1.0%	$627.39	$435.27 ▼ $694.33	$243.30B	0.87	2.39 million shs	1.58 million shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DHR Danaher	0.00%	+2.86%	+9.76%	+10.57%	+7.32%
ILMN Illumina	0.00%	+1.88%	+38.21%	+46.25%	+184.49%
QGEN Qiagen	0.00%	+1.53%	+7.91%	+9.40%	-9.65%
TMO Thermo Fisher Scientific	0.00%	+0.42%	+9.01%	+24.97%	+22.76%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DHR Danaher	$220.15 +1.2%	$211.38	$160.93 ▼ $242.80	$154.52B	0.76	4.61 million shs	3.93 million shs
ILMN Illumina	$278.17 +5.1%	$227.18	$88.00 ▼ $309.35	$42.00B	1.41	4.55 million shs	1.89 million shs
QGEN Qiagen	$45.42 +2.0%	$43.47	$32.53 ▼ $57.81	$9.35B	0.61	2.31 million shs	1.26 million shs
TMO Thermo Fisher Scientific	$658.23 +1.0%	$627.39	$435.27 ▼ $694.33	$243.30B	0.87	2.39 million shs	1.58 million shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DHR Danaher	0.00%	+2.86%	+9.76%	+10.57%	+7.32%
ILMN Illumina	0.00%	+1.88%	+38.21%	+46.25%	+184.49%
QGEN Qiagen	0.00%	+1.53%	+7.91%	+9.40%	-9.65%
TMO Thermo Fisher Scientific	0.00%	+0.42%	+9.01%	+24.97%	+22.76%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DHR Danaher	2.91	Moderate Buy	$235.23	6.85% Upside
ILMN Illumina	2.44	Hold	$222.19	-20.13% Downside
QGEN Qiagen	2.43	Hold	$43.51	-4.22% Downside
TMO Thermo Fisher Scientific	2.80	Moderate Buy	$634.86	-3.55% Downside

Current Analyst Ratings Breakdown

Latest ILMN, QGEN, TMO, and DHR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/8/2026	TMO Thermo Fisher Scientific	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C+) ➝ Buy (B-)
10/7/2026	TMO Thermo Fisher Scientific	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$650.00 ➝ $750.00
10/7/2026	ILMN Illumina	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Underweight	$160.00 ➝ $200.00
10/7/2026	DHR Danaher	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$230.00 ➝ $255.00
10/5/2026	DHR Danaher	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$215.00 ➝ $250.00
10/5/2026	ILMN Illumina	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$230.00 ➝ $310.00
10/1/2026	ILMN Illumina	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$226.00 ➝ $305.00
10/1/2026	DHR Danaher	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$200.00 ➝ $250.00
9/29/2026	ILMN Illumina	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$220.00 ➝ $300.00
9/28/2026	ILMN Illumina	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$225.00 ➝ $305.00
9/25/2026	TMO Thermo Fisher Scientific	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$720.00

(Data available from 10/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DHR Danaher	$24.57B	6.30	$11.39 per share	19.33	$74.38 per share	2.96
ILMN Illumina	$4.34B	9.67	$6.71 per share	41.43	$17.82 per share	15.61
QGEN Qiagen	$2.09B	4.48	$3.41 per share	13.33	$17.89 per share	2.54
TMO Thermo Fisher Scientific	$44.56B	5.46	$30.42 per share	21.64	$142.17 per share	4.63

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DHR Danaher	$3.61B	$5.63	39.10	23.77	2.74	15.95%	11.04%	6.81%	10/21/2026 (Estimated)
ILMN Illumina	$850M	$5.36	51.90	45.60	3.94	18.36%	29.84%	12.17%	10/29/2026 (Estimated)
QGEN Qiagen	$424.88M	$1.95	23.27	17.40	4.52	19.49%	14.47%	8.34%	11/3/2026 (Estimated)
TMO Thermo Fisher Scientific	$6.70B	$18.59	35.41	23.93	2.75	15.04%	17.09%	8.12%	10/21/2026 (Estimated)

Latest ILMN, QGEN, TMO, and DHR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/3/2026	Q3 2026	QGEN Qiagen	$0.6210	N/A	N/A	N/A	$535.62 million	N/A
10/29/2026	Q3 2026	ILMN Illumina	$1.36	N/A	N/A	N/A	$1.15 billion	N/A
10/21/2026	Q3 2026	DHR Danaher	$1.92	N/A	N/A	N/A	$6.56 billion	N/A
10/21/2026	Q3 2026	TMO Thermo Fisher Scientific	$6.40	N/A	N/A	N/A	$11.95 billion	N/A
8/5/2026	Q2 2026	QGEN Qiagen	$0.5980	$0.62	+$0.0220	$0.50	$527.50 million	$535.04 million
7/30/2026	Q2 2026	ILMN Illumina	$1.23	$1.31	+$0.08	$1.35	$1.13 billion	$1.16 billion
7/23/2026	Q2 2026	TMO Thermo Fisher Scientific	$5.71	$6.03	+$0.32	$4.68	$11.71 billion	$11.99 billion
7/20/2026	Q2 2026	DHR Danaher	$1.85	$1.94	+$0.09	$1.23	$6.12 billion	$6.27 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DHR Danaher	$1.60	0.73%	+12.20%	28.42%	2 Years
ILMN Illumina	N/A	N/A	N/A	N/A	N/A
QGEN Qiagen	$0.35	0.77%	N/A	17.95%	N/A
TMO Thermo Fisher Scientific	$1.88	0.29%	+14.34%	10.11%	8 Years

Latest ILMN, QGEN, TMO, and DHR Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
9/15/2026	DHR Danaher	quarterly	$0.40	0.72%	9/30/2026	9/30/2026	10/30/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DHR Danaher	0.48	1.65	1.25
ILMN Illumina	0.53	1.80	1.40
QGEN Qiagen	0.48	2.85	2.31
TMO Thermo Fisher Scientific	0.74	1.55	1.18

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DHR Danaher	79.05%
ILMN Illumina	89.42%
QGEN Qiagen	70.00%
TMO Thermo Fisher Scientific	89.23%

Insider Ownership

Company	Insider Ownership
DHR Danaher	10.80%
ILMN Illumina	2.90%
QGEN Qiagen	9.00%
TMO Thermo Fisher Scientific	0.33%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DHR Danaher	60,000	702.99 million	627.06 million	Optionable
ILMN Illumina	8,650	151.00 million	146.62 million	Optionable
QGEN Qiagen	5,654	206.07 million	187.53 million	Optionable
TMO Thermo Fisher Scientific	125,000	369.75 million	368.53 million	Optionable

ILMN, QGEN, TMO, and DHR Headlines

Recent News About These Companies

Thermo Fisher Stock Trades at a Premium. Can Its Earnings Keep Up?

October 11 at 2:19 PM | finance.yahoo.com

Thermo Fisher Stock Trades at a Premium. Can Its Earnings Keep Up?

October 11 at 2:11 PM | insidermonkey.com

Thermo Fisher Scientific Inc. $TMO Stock: Farther Finance Advisors LLC Grows Stake

October 10 at 3:44 AM | marketbeat.com

Thermo Fisher Scientific Inc. $TMO Stock Holdings Trimmed by Castle Rock Wealth Management LLC

October 9 at 7:11 PM | marketbeat.com

Thermo Fisher (TMO) Gets a Buy from Barclays

October 9 at 3:03 PM | theglobeandmail.com

Thermo Fisher Scientific Inc. $TMO Stock Position Trimmed by Douglas Lane & Associates LLC

October 9 at 1:08 PM | marketbeat.com

Thermo Fisher Scientific's Q3 2026 Earnings: What to Expect

October 9 at 9:31 AM | barchart.com

Mn Services Vermogensbeheer B.V. Purchases 1,900 Shares of Thermo Fisher Scientific Inc. $TMO

October 9 at 4:31 AM | marketbeat.com

Thermo Fisher Scientific Inc. $TMO Stock Sold by Bell Asset Management Ltd

October 9 at 3:28 AM | marketbeat.com

Thermo Fisher Scientific Inc. $TMO Stock Position Trimmed by Professional Advisory Services Inc.

October 8 at 7:36 PM | marketbeat.com

What Could Thermo Fisher Scientific (TMO) Change With Its New Digital CMC Consortium?

October 8 at 7:10 PM | finance.yahoo.com

47,720 Thermo Fisher Scientific Inc. $TMO Shares Purchased by Fenimore Asset Management Inc

October 8 at 7:03 PM | marketbeat.com

3,688 Thermo Fisher Scientific Inc. $TMO Shares Acquired by Atwood & Palmer Inc.

October 8 at 7:03 PM | marketbeat.com

Why Thermo Fisher Scientific (TMO) Is Back In The Spotlight

October 8 at 2:09 PM | finance.yahoo.com

Thermo Fisher Scientific Inc. $TMO Stock Purchased by Artemis Investment Management LLP

October 8 at 1:19 PM | marketbeat.com

Thermo Fisher Scientific Inc. $TMO Stock Bought by Quintet Private Bank Europe S.A.

October 8 at 1:05 PM | marketbeat.com

Thermo Fisher Scientific Slides as Investors Appear to Take Profits Ahead of Earnings

October 8 at 10:51 AM | quiverquant.comQ

Pharmaceutical CRO Market Forecasts Growth from $45.33B (2025) to $83.31B by 2033, Profiling IQVIA, ICON, Thermo Fisher, Medpace & 5 Other Key Players

October 8 at 9:09 AM | finance.yahoo.com

PCR Market Report Forecasts qPCR, Digital PCR and Multiplex Testing Growth, Profiling 89 Companies Including Roche and Thermo Fisher

October 8 at 9:09 AM | finance.yahoo.com

Thermo Fisher Scientific Inc. $TMO Shares Sold by Congress Asset Management Co.

October 8 at 3:12 AM | marketbeat.com

Quantum BioPharma (QNTM) Enlists Thermo Fisher's Clinical Research Business to Launch Phase 2 Lucid-MS Trial

October 7, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ILMN, QGEN, TMO, and DHR Company Descriptions

Danaher NYSE:DHR

$220.15 +2.69 (+1.24%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$219.68 -0.47 (-0.21%)

As of 10/9/2026 07:54 PM Eastern

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Illumina NASDAQ:ILMN

$278.17 +13.60 (+5.14%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$278.54 +0.37 (+0.13%)

As of 10/9/2026 07:59 PM Eastern

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Qiagen NYSE:QGEN

$45.42 +0.89 (+2.01%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$45.40 -0.03 (-0.06%)

As of 10/9/2026 07:30 PM Eastern

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Thermo Fisher Scientific NYSE:TMO

$658.23 +6.25 (+0.96%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$653.11 -5.12 (-0.78%)

As of 10/9/2026 07:59 PM Eastern

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ILMN, QGEN, TMO, and DHR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ILMN, QGEN, TMO, and DHR Earnings

Compare Dividends

Latest ILMN, QGEN, TMO, and DHR Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ILMN, QGEN, TMO, and DHR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ILMN, QGEN, TMO, and DHR Company Descriptions

Danaher NYSE:DHR

Illumina NASDAQ:ILMN

Qiagen NYSE:QGEN

Thermo Fisher Scientific NYSE:TMO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ILMN, QGEN, TMO, and DHR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ILMN, QGEN, TMO, and DHR Earnings

Compare Dividends

Latest ILMN, QGEN, TMO, and DHR Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ILMN, QGEN, TMO, and DHR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

ILMN, QGEN, TMO, and DHR Company Descriptions

Danaher NYSE:DHR

Illumina NASDAQ:ILMN

Qiagen NYSE:QGEN

Thermo Fisher Scientific NYSE:TMO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools